Zoekresultaten - 8 results
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.
vaccine effectiveness data from the literature. We included data for six age groups (25-49 years, 50-59 years, ≥60 years, 60-69 years, 70-79 years, and ≥80 years). To be included in the analysis, CAT needed ...
A survey of the representativeness and usefulness of wastewater-based surveillance systems in 10 countries across Europe in 2023
the diverse landscape of WBS in Europe, offering insights for future developments and collaborations. Furthermore, it highlights the need for further integration of WBS into other European ...
Population health information research infrastructure—from data to public health actions
Research Infrastructure (PHIRI). The EU and its Member States need strong and resilient HIS that can deliver timely, sound and high-quality health information to support policymaking, strengthen (health) ...
BY-COVID Educational Toolkit
to specific needs. Health Topics: Coronavirus Coronavirus Coronavirus Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: https://doi.org/10.5281/zenodo.8363521 File: Version: ...
Time series modelling for wastewater-based epidemiology of COVID-19: A nationwide study in 40 wastewater treatment plants of Belgium, February 2021 to June 2022
observed in terms of explaining incident cases. These findings are of practical importance to WBE practitioners and show that the early-warning potential of WBE is WWTP-specific and needs validation. Health ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
be needed to achieve optimal protection against variants of concern in this vulnerable population group. Health Topics: Coronavirus Coronavirus Coronavirus Manuscript versions: DOI: ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
prevalence of anti- SARS-CoV-2 antibodies increased in wave 2 from 22.5% (27/09-24/10) to 36.5% (25/10-21/11). However, caution is needed to interpret these figures, because in wave 2 the number of ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
explained by socioeconomic differences in the prevalence of chronic diseases. Further research is needed to explore if this difference could be related to a lower immune response of people with certain ...